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Abstract
The 2-deoxy-D-ribose-5-phosphate aldolase (DERA) offers access to highly desirable build-
ing blocks for organic synthesis by catalyzing a stereoselective C-C bond formation
between acetaldehyde and certain electrophilic aldehydes. DERA´s potential is particularly
highlighted by the ability to catalyze sequential, highly enantioselective aldol reactions.
However, its synthetic use is limited by the absence of an enantiocomplementary enzyme.
Here, we introduce the concept of homologous grafting to identify stereoselectivity-deter-
mining amino acid positions in DERA. We identified such positions by structural analysis of
the homologous aldolases 2-keto-3-deoxy-6-phosphogluconate aldolase (KDPG) and the
enantiocomplementary enzyme 2-keto-3-deoxy-6-phosphogalactonate aldolase (KDPGal).
Mutation of these positions led to a slightly inversed enantiopreference of both aldolases to
the same extent. By transferring these sequence motifs onto DERA we achieved the
intended change in enantioselectivity.
Introduction
Protein engineering offers the opportunity to alter protein properties such as stability, substrate
specificity, and conversion rates, respectively. However, addressing stereoselectivity still
remains challenging for such endeavors, and this holds especially true in cases with no enantio-
complementary enzyme being available. In a summary of successful changes of enzyme enan-
tioselectivity, Faber, Kazlauskas and coworkers described that these were achieved in most
cases by altering the substrate binding mode [1]. Notably, even a single amino acid exchange
can be sufficient to invert stereoselectivity as demonstrated, e.g., for thiamine diphosphate-
dependent enzymes [2, 3]. The key step for rational protein design is the identification of these
positions for mutagenesis. According to a study of Kazlauskas et al., amino acids close to the
active site are often the more effective points of attack for changing enantioselectivity [4]. A
fruitful approach to identify these stereoselectivity-determining positions is the analysis of
enzyme families to expose conserved amino acids as summarized by Pleiss [5]. However,
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understanding the molecular mechanism of an enzyme´s enantiopreference is still challenging,
even when a crystal structure is known. Grafting of specific patterns from related enzymes can
be an alternative to generate a protein with the desired function [6, 7]. Referring to enzyme
selectivity, Pazmiño et al. could identify amino acid positions, where variations led to an
improved enantioselectivity by comparison of two sequence-related cyclopentanone monooxy-
genases, with one protein structure being modeled [8].
Enantiocomplementarity is essential for organic synthesis endeavors: enantiomerically pure
building blocks are required in both enantiomeric forms. In particular, the aldol motif is a key
to many synthetic endeavors. Besides conventional aldol reactions, the use of aldolases as bio-
catalysts became popular during the last two decades. Especially the 2-deoxy-D-ribose-5-phos-
phate aldolase (DERA) is of interest because it catalyzes aldol reactions between the
nucleophilic acetaldehyde and certain electrophilic aldehydes. Interestingly, DERA catalyzes
sequential aldol reactions facilitating access to lactols with up to two newly formed stereogenic
centers in a single sequence [9–13]. However, the synthetic use of DERA is limited by the lack
of a known natural enantiocomplementary DERA. The chemoselectivity of DERA was already
enhanced by Jennewein et al., allowing DERA to accept chloroacetaldehyde as a substrate [14],
and Wong and coworkers improved DERA´s use of non-phosphorylated electrophiles [15].
However, so far no alteration of DERA´s enantio- or diastereoselectivity has been attempted.
Thus, the stereoinversion of DERA is optimal for applying and testing the grafting approach
from homologous aldolases.
We identified amino acid positions responsible for enantioselectivity and activity by com-
paring homologous aldolases, the enantiocomplementary pyruvate-dependent 2-keto-
3-deoxy-6-phosphogluconate aldolase (KDPG) and 2-keto-3-deoxy-6-phosphogalactonate
aldolase (KDPGal). All three aldolases are (αβ)8-barrel (TIM-barrel) proteins and, as class I
aldolases, form an intermediate Schiff base between a particular lysine in their active site and
their nucleophilic substrate during catalysis. While using a common electrophile, glyceralde-
hyde-3-phosphate, these aldolases merely differ by their specificity for a certain nucleophile,
acetaldehyde for DERA and pyruvate for KDPG and KDPGal (Fig 1). In our homologous graft-
ing approach we used geometric analyses and molecular dynamics (MD) simulations of KDPG
and KDPGal to identify their determinants of stereoselectivity, which were then transferred
onto DERA, leading to the intended change in its enantioselectivity.
Materials and Methods
Molecular Dynamics Simulations
The crystallographic protein structures of KDPG (PDB ID: 1eun [16]) and KDPGal (PDB ID:
2v81 [17]) were obtained from the Protein Data Bank PDB [18]. For KDPG, which forms a tri-
mer in the crystallographic structure, only chain A was used. Crystallographic waters assigned
to the prepared protein chains were retained for the simulation. Sulfate ions were removed.
Selenomethionines were replaced by methionines, retaining the crystallographic conformation.
Protein hydrogen atoms and side chain conformations of asparagines, glutamines, and histi-
dines were assigned by REDUCE [19]. Hydrogens of crystal waters were added by the xLEaP
program from the AMBER 9 package of molecular simulations programs [20].
MD simulations (MD) were performed with the AMBER 9 package of molecular simulation
programs [20] using the Cornell et al. force field [21] with modifications introduced by Hornak
et al. (ff99SB) [22]. Protein structures including crystallographic waters were solvated in a trun-
cated octahedron of TIP3P water [23] such that the distance between the edges of the box and
the closest solute atom was at least 11 Å. Periodic boundary conditions were applied using the
particle mesh Ewald (PME) method [24] to treat long-range electrostatic interactions. Bond
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lengths of bonds to hydrogen atoms were constrained by SHAKE [25, 26]. The time step for all
MD simulations was 2 fs, and a direct-space non-bonded cutoff of 8 Å was applied. After mini-
mization the system was heated over 50 ps from 100 K to 300 K using canonical ensemble
(NVT) MD. Then, the solvent density was adjusted over 50 ps using isothermal-isobaric
ensemble (NPT) MD. Positional restraints applied during thermalization (with a force constant
of 5 kcal mol-1 Å-2) were reduced in a stepwise manner over 50 ps followed by 50 ps of unre-
strained canonical ensemble (NVT) MD at 300 K with a time constant of 2 ps for heat bath
coupling to a Berendsen thermostat. Production runs were carried out for 10 ns; snapshots of
the structure were saved every 1 ps. Interatomic distances were calculated for all saved snap-
shots by the PTRAJ program from the AMBER 9 package of molecular simulations programs
[20].
Biological Procedures
DNAmanipulation: Enzymes, PCR reagents, and oligonucleotides were purchased from stan-
dard suppliers. PCR reactions were performed in 100 μl thin-wall tubes using a VWR Doppio
gradient-thermocycler. DNA amounts were determined using a Thermo Fischer Scientific
NanoDrop 2000c spectrophotometer. Commercially available kits were applied for DNA isola-
tion and purification. DNA sequencing was conducted at SEQLAB or GATC Biotech. All prim-
ers are listed in S1 Table.
Cloning of KDPGEC aldolase. The gene edaEC encoding for KDPG from E. coli was
amplified from the isolated genomic DNA of the strain DH5α using the primer pair edaEC_N-
deI_fw and edaEC_XhoI_rv together with Pfu polymerase (10 min 95°C; 35x[45 s 95°C; 45 s
62°C; 45 s 72°C]; 10 min 72°C). The amplified DNA products were restricted by restriction
endonucleases NdeI and XhoI and ligated into the likewise restricted and dephosphorylated
Fig 1. The natural reaction of the enantiocomplementary pyruvate–dependent aldolases KDPG and KDPGal (top) and
of DERA (bottom). An enzyme that is diastereoselectively complementary to DERA (“DEXA” = 2-deoxy-D-xylose-
5-phosphate aldolase) does not exist in nature as indicated by the dashed line.
doi:10.1371/journal.pone.0156525.g001
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vector pET22b (Novagen). The aldolase gene was expressed cytosolically with a C-terminally
fused hexa-histidine tag. The obtained vector is referred to as pET22b::eda.
Generation of KDPGEC-variants. According to the method of Tillett and coworkers a
sequence and ligation independent cloning was carried out to obtain the mutants [27]. Two
pairwise PCRs were carried out using Phusion polymerase (ThermoScientific Fischer) and the
primer pairs edaEC_chimI_fw and edaEC_chimI_rv_t as well as edaEC_chimI_fw_t and
edaEC_chimI_rv, respectively (30 s 98°C; 25x[10 s 98°C; 30 s 55–65°C; 2 min 72°C]; 10 min
72°C; template: pET22b::eda). After the PCR the two mixes were combined and used for trans-
formation of chemically competent E. coli DH5α. To introduce mutation T161V the same pro-
cedure was used with edaEC_T161V_fw and edaEC_T161V_rv_t as well as
edaEC_T161V_fw_t and edaEC_T161V_rv, respectively, on the templates pET22b::eda or
pET22b::eda_chimI (see above) to obtain both the single and the double mutant.
Cloning of KDPGalEC aldolase. The procedure for the gene encoding for KDPGalEC was
exactly the same as for the gene encoding for KDPGEC but with the primer pair dgoaEC_N-
deI_fw and dgoaEC_XhoI_rv. The obtained vector is referred to as pET22b::dgoa.
Generation of KDPGalEC-variants. A round-the-horn PCR was used to implement the
mutations onto the KDPGal gene [28–30]. The inverse PCR was carried out using Phusion
polymerase onto pET22b::dgoa as template and as oligonucleotides dgoaEC_chimI_fw and
dgoaEC_chimI_rv [6 min 95°C; 35x(30 s 95°C; 30 s 45–65°C; 1.5 min 70°C); 10 min 70°C].
The vector pET22b::dgoa_chimI was obtained. The same procedure was used with
dgoaEC_V154T_fw and dgoaEC_V154T_rv onto pET22b::dgoa and pET22b::dgoa_chimI to
obtain both the single and the double mutant.
Generation of a DERAEC library. The gene deoCEC encoding E. coli DERAEC was ampli-
fied (10 min 95°C; 35x[45 s 95°C; 45 s 61°C; 45 s 72°C]; 10 min 72°C) from E. coli K12 chromo-
somal DNA using deocEC_NdeI_fwd and deocEC_EcoRI_rev as primers (S1 Table #59 and
#60). The ligation with pET-21a(+) was done using the sticky ends generated by NdeI and
EcoRI. The resulting construct is pET-21a::deocEC wt [31]. A DERA enzyme library consisting
of 49 variants was constructed by exchanging the amino acid codons for T18, L20, and A203
within the wildtype (wt) gene to codons for 12 amino acids (R, N, D, C, G, H, I, L, F, S, Y, V,
except for L20N and L20C) and deleting the amino acid codons for G204 and G205 as well as
pairwise combinations of these single mutations (S1 Fig).
General Protocol for QuikChange PCR: PCR reactions were performed in a total volume of
50 μl containing 10 μl 5x Phusion HF buffer, 2 U PhusionTM polymerase, ca. 30 ng template
DNA, 200 μM dNTPs, 0.2 μM of each primer, and water. The applied temperature protocol
was 30 sec at 95°C, 16 cycles of 30 sec at 95°C, 1 min at 50–65°C, and 6 min at 68°C, with a
final step of 10 min at 68°C. Amplification was confirmed by agarose gel electrophoresis (1%
agarose gels). PCR products were incubated with 10 U DpnI at 37°C overnight to digest tem-
plate DNA.
General Protocol for Round-The-Horn PCR (RTH PCR): PCR reactions were performed in
a total volume of 20 μl containing 4 μl 5x Phusion HF buffer, 0.4 U PhusionTM polymerase, ca.
30 ng template DNA, 200 μM dNTPs, 6.25 nM of each primer, and water. The applied temper-
ature protocol was 30 sec at 98°C, 25 cycles of 10.2 sec at 98°C, 30 sec at 55–70°C, and 2 min at
72°C, with a final step of 10 min at 70°C. Amplification was confirmed by agarose gel electro-
phoresis (1% agarose gels). Ligation with 2 μl T4 ligation buffer and 1 μl T4 ligase was per-
formed at room temperature for 1 h. The ligated PCR products were incubated with 10 U DpnI
at 37°C overnight to digest template DNA.
General Procedure for Plasmid Preparation: Chemically competent E. coli DH5α cells were
transformed with the PCR products, followed by selection on LB agar plates supplemented
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with Ampicillin. Inoculation of a 5 ml overnight culture with LB medium supplemented with
Ampicillin by a single colony enabled plasmid preparation.
Expression and purification of the pyruvate-dependent aldolases. For recombinant,
homologous expression of KDPG or KDPGal and their variants, chemically competent cells
[32] of E. coli BL21(DE3) were transformed with the respective vectors and selected on LB agar
plates supplemented with ampicillin. In a baffled 3 l Fernbach flask 1 l TB-medium [1.2% (w/v)
Trypton, 2.4% (w/v) yeast extract, 0.4% (v/v) glycerol, 0.231% (w/v) KH2PO4, and 1.254%
(w/v) K2HPO4, 100 μg ml
-1 ampicillin] were inoculated with 1% (v/v) of an overnight culture.
The culture was incubated for 9 h at 20°C (120 rpm), induced with 0.1 mM iso-propylthio
galactoside (IPTG), and incubated likewise for additional 15 h. Cells were harvested by centri-
fugation and stored at -20°C.
Frozen cells (up to 12.5 g) were thawed by suspending in purification buffer [20% cells
(w/v)] and disrupted using a FRENCH press Cell Disruptor Cell (Thermo Electron, Oberhausen
GmbH). The crude extract was centrifuged for 20 min at 20,000 rcf and 4°C to obtain the cell
free crude extract, which was applied to a 5 ml Ni-NTA column equilibrated with purification
buffer (Qiagen,Hilden). The chromatographic elution was carried out using an ÄKTA Purifier
System (GE Healthcare,Munich): 6 CV purification buffer with 0 mM imidazole; 6 CV purifi-
cation buffer with 30 mM imidazole, and elution with 6 CV purification buffer with 250 mM
imidazole. The eluate was concentrated at 4°C using Vivaspin 20 MWCO 10 kDa ultra-concen-
trators (Sartorius Stedim Biotech S.A., France). Imidazole was finally removed by PD-10 desalt-
ing columns (GE Healthcare,Munich) equilibrated on purification buffer. Up to 150 mg
purified protein was obtained from 1 l TB-medium. Purification buffer: 20 mM potassium
phosphate, pH 6.5. Elution buffer concentrate: 20 mM potassium phosphate, 2 M imidazole/
HCl, pH 6.5. Purification samples of KDPG and KDPGal aldolase were analyzed by subjecting
equal amounts of protein (determined by Bradford assay [33]) to the SDS-PAGE using colloi-
dal Coomassie stain [34] (S2 Fig).
Expression and purification of DERA wt and variants. Recombinant expression of
DERA was performed in 3 l baffled Fernbach flasks using E. coli BL21(DE3) cells. Chemically
competent cells were transformed with the respective DERA-vectors, followed by selection on
LB plates supplemented with ampicillin. 1 l terrific broth (TB) with 100 μg ml-1 ampicillin was
inoculated with a 5 ml overnight culture prepared from a single colony and grown at 37°C.
After incubation at 25°C and 120 rpm for 8 h, expression of deoC gene was induced by the
addition of 0.1 mM IPTG. After prolonged incubation of 15 h at 25°C, cells were harvested. For
disruption using Ultrasonic Desintegrator Sonoplus HP 2070 (Bandelin, Berlin), the cells were
suspended 20% (w/v) in triethanol amine buffer (100 mM, pH 7). Centrifugation at 18,000 rcf
and 4°C resulted in cell free crude extract. For purification 2 ml of the cell free crude extract
were loaded on a Q Sepharose HP column (5 ml) applied in an ÄKTA Purifier System (GE
Healthcare,Munich) and eluted with triethanol amine buffer (100 mM, pH 7). The eluate was
concentrated at 4°C using Vivaspin 20 MWCO 10 kDa ultra-concentrators (Sartorius Stedim
Biotech S.A., France).
Stereoselectivity Screening for Pyruvic Acid-Dependent Aldolases
For the stereoselectivity screening assay, the protein was isolated as described in the “biological
procedures”. 50 mg of purified protein were dissolved in 10 ml of 20 mM potassium phosphate,
1 M sodium pyruvate, pH 6.5. The reaction was started by addition of 200 μl propanal (1). This
mixture was shaken for 16 min (300 rpm) in a 50 ml reaction tube at 30°C. To facilitate the lac-
tonization of the aldol product 3, 100 μl of concentrated sulfuric acid was added and the reac-
tion mixture was heated (with closed lid) to 60°C for 30 min. After chilling to ambient
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temperature, 5 ml ethyl acetate was added for extraction. The extract was employed for chro-
matographic analysis. Samples without enzyme were used as negative controls. 2-Oxo-4-ethyl-γ-
butyro-lactone (4): Geometrical configurations were assumed to be as present in the natural sub-
strate, although CIP priority changes. GC: Rt (R-enantiomer) = 24.4 min; Rt (S-enantiomer) =
26.5 min; 0.6 bar H2; [60°C isothermic for 5 min, 5°C min
-1 to 150°C (5 min isothermic)]; MS
(EI, 70 eV): m/z (%) = 128 (21) [M+], 99 (66) [(M-Et)+], 83 (100), 72 (60), 57 (36); 1H-NMR (600
MHz, CDCl3): keto-form δ [ppm] = 1 (t,
3J2’,1’ = 7.42 Hz, 3 H, 2’-H); 1.79 (m, 1 H, 1’a-H); 1.84
(m, 1 H. 1’b-H); 2.51 (dd, 2J3a,3b = 19.9 Hz,
3J3a,4 = 5.4 Hz, 1 H, 3a-H); 2.99 (dd,
2J3b,3a = 19.9
Hz, 3J3b,4 = 7.3 Hz, 1 H, 3b-H); 4.8 (m, 1 H, 4-H);
1H-NMR (600MHz, CDCl3): enol-form δ
[ppm] = 0.93 (t, 3J2’,1’ = 1.9 Hz, 3 H, 2’-H); 1.67 (m, 1 H, 1’a-H); 1.72 (m, 1 H, 1’b-H); 4.84
(ddd, 3J4,3 = 1.9 Hz,
3J4,1’a = 5.67 Hz,
2J4,1’b = 7.17 Hz, 1 H, 4-H); 5.9 (s(broad), 1 H, OH); 6.14
(d, 3J3,4 = 1.9 Hz, 1 H, 3-H)
Protocol of DERA-Catalyzed Reactions for Library Screenings
The DERA catalyzed aldol reaction of acetaldehyde and propanal to (R)- or (S)-hydroxypenta-
nal was performed in analytical scale, followed by a derivatization with 2,4-dinitrophenylhy-
drazine (2,4-DNPH). The products were extracted and measured by chiral HPLC. A stock
solution, containing 7 μl of propanal (0.10 mmol), 7 μl of acetaldehyde (0.12 mmol, 1.3 eq.),
and 14 μl dimethyl sulfoxide (0.2 mmol, 2.0 eq.), were pipetted to 0.5 ml of triethanolamine
buffer (0.1 M, pH 7). After addition of 20 μl enzyme solution (cell free crude extract), the tubes
were shaken for 16 h at 25°C and 200 rpm. For the derivatization step a solution of 40 mg
2,4-DNPH (0.2 mmol) and 7 μl conc. HCl (0.31 mmol) in 0.5 ml dimethyl sulfoxide was added
to the DERA reaction mixture and stirred for 2 h at 50°C, 300 rpm. Extraction and sample
preparation for HPLC was done according to Dick et al. [35] Samples without enzyme as well
as a reaction with E. coli cells transformed with an empty vector were used as negative controls.
HPLC measurements were performed on a Dionex instrument consisting of a LPG-3400A
pump, a WPS-3000TSL autosampler, a DAD-3000 UV-detector, and a TCC-3000SD oven.
The instrument was fitted with a Daicel Chiralpak IA (250 mm x 4.6 mm) adjusted to 25°C. As
solvent, a 80:20 (v/v) n-heptane/2-propanol-mixture was used applying a flow rate of 0.5 ml
min-1. Compounds were solved in 90:10 (v/v) n-heptane/2-propanol-mixtures and measured
at 345 nm. HPLC conditions: Chiralpak IA, 0.5 mlmin-1, 80:20 (v/v) n-heptane/2-propanol,
345 nm: (ent-R)-7 tR = 70.9 min, (ent-S)-7 tR = 79.0 min. The reference substances were synthe-
sized according to ref. [35].
Kinetic measurements with DERA
The activity was measured for the retro-aldol reaction of the natural substrate 2-deoxy-D-
ribose-5-phosphate to glyceraldehyde-3-phosphate, which is converted by auxiliary enzymes
to glycerol-3-phosphate under NADH consumption. The reaction is monitored on a photome-
ter at 340 nm. The assay was done according to Dick et al. [36].
Results and Discussion
Identification of Key-Residues for KDPG and KDPGal
DERA is the only aldolase using acetaldehyde as natural nucleophile (donor). Thus, there is no
enantiocomplementary enzyme available. We therefore set out to learn from the homologous
aldolases KDPG and KDPGal from E. coli how these enzymes accomplish enantioselectivity
and use this knowledge to invert the enantioselectivity of DERA. Like DERA, these enzymes
have an (αβ)8-architecture and belong to the type I aldolases. In contrast to DERA, KDPG and
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KDPGal aldolase utilize pyruvate rather than acetaldehyde as nucleophile. However, they natu-
rally catalyze the hydrolysis of the respective 2-keto-3-deoxy-hexose acid to pyruvate and glyc-
eraldehyde-3-phosphate, which is the same electrophile as in the natural DERA reaction (Fig
1). Our hypothesis is that the active sites of DERA as well as of KDPG and KDPGal consist of
one part that is adapted to the nucleophile and another part that is adapted to the electrophile
(Fig 2). The molecular basis of stereoselectivity should be inherent to the electrophilic part of
the active site, which is presumably similar in both classes of aldolases, because the nucleophile
adopts the very same position independent of the kind of pyruvate-dependent aldolase. Thus,
the first step in designing an enantiocomplementary DERA was to identify stereodeterminants
in the electrophilic part of the active site of the pyruvate-dependent aldolases. The identified
stereodeterminants shall then be transferred onto DERA to alter its stereoselectivity.
Slight conformational variations within the active site may affect the respective enantios-
electivity. Hence, MD simulations were conducted to account for the dynamic behavior of the
active sites. The MD simulations were carried out over 10 ns with snapshots extracted every 1
ps. The stereoselectivity-determining region was defined as all atoms within 6 Å radius of the
newly formed stereogenic center (Fig 3E). The geometry of the active site was analyzed by cal-
culating the distance of particular atoms to the ε-amino group of the active lysine as a reference
point as to where the substrate would be present.
Analyses of the MD simulations revealed that most measured distances in the active sites of
KDPG and KDPGal are similar. However, some amino acids at homologous sequence posi-
tions have significantly different distances to the ε-amino group of the active lysine, namely
I12/V20 (in β1-sheet), E37/E45 (in β2-sheet), and V154/T161 (in β7-sheet), in the order
KDPGal/KDPG aldolase respectively (Fig 3A–3D and 3F). The glutamate residues E37/E45 are
part of the essential proton shuttling system enabling the formation of the nucleophilic
enamine species. Hence, we assumed that major interactions are formed between these gluta-
mates and the nucleophile, but not to the newly formed stereogenic center. Thus, we focused
our design efforts on the two remaining sites, I12/V20 and V154/T161.
Fig 2. Top view on KDPGal (PDB ID: 2V82) [17]. The substrate is highlighted in stick representation. We
hypothesize that the blue part of the protein is adapted to fix the nucleophilic carbonyl (here pyruvate),
whereas the orange part is adapted to the electrophilic carbonyl (here glyceraldehyde-3-phosphate) and,
thus, provides the basis for stereoselectivity.
doi:10.1371/journal.pone.0156525.g002
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Site V154/T161 was previously shown to affect stereoselectivity in KDPG and KDPGal
aldolase, respectively [17, 38–41]. To investigate this, we introduced V154TKDPGal and
T161VKDPG single point mutations. So far, the I12/V20 site has not been investigated as to its
influence on the stereoselectivity. However, crystal structures (Fig 3) suggest that single point
mutations of this site may not be sufficient to affect stereoselectivity because the β1-sheet places
V20KDPG even closer to the active lysine than the more extended homologous I12KDPGal. In
particular, P19KDPG caused a kink in the β1-sheet, that way pushing V20KDPG deeper into the
active site pocket than I12KDPGal. Thus, to test the influence of the I12/V20 site, we transferred
the entire β1-sheet of KDPG to KDPGal (chimβ1;KDPGal: V17L, V18I, P19A, V20I, I21L) and
vice versa (chimβ1;KDPG: L9V, I10V, A11P, I12P, L13I). Finally, combinations of the single
point mutations and the β-sheet transfer were introduced (chimβ1 T161VKDPG and chimβ1
V154TKDPGal).
To further support the suggested mutation sites, we conducted phylogenetic analyses of bac-
terial KDPG and KDPGal aldolases (Fig 4). The I12/V20 site found by MD simulations is virtu-
ally fully conserved throughout all sequences, whilst the degree of conservation in the
surrounding patches varies strongly. The P19 in KDPG mentioned above is highly conserved
as is the homologous position A11 KDPGal. This supports our hypothesis that single amino
acid exchanges at the I12/V20 site alone are insufficient to affect the stereoselectivity.
Altering Stereoselectivity in Pyruvate-Dependent Aldolases
The effect of the introduced mutations on the aldolases´ stereoselectivity was investigated by
enzymatic reactions in synthetic (aldol) direction using pyruvic acid (2) as nucleophile and
Fig 3. Geometric analyses of homologous aldolases. (A) – Superposition of DERA (PDB ID: 1JCL, blue) [37], KDPG (PDB ID: 1EUA, orange) [16], and
KDPGal (PDB ID:2V82, green) [17] illustrates the structural similarity of these TIM-barrel proteins. (B-D) – Close-up views of the active sites of the three
proteins. The active lysine is marked by a triangle (▼). (E) – Superposition of the active sites of KDPG and KDPGal aldolase. Atoms within a radius of 6 Å
around the newly formed stereogenic center are indicated as spheres. (F) – Distances fromMD simulations between the ε-amino group of the active lysine
and all atoms within the 12 Å-Ø-sphere around the newly formed stereogenic center for both the KDPG and KDPGal aldolase, respectively. The mean
values over all conformations of the MD simulation are given; bars indicate the standard deviation.
doi:10.1371/journal.pone.0156525.g003
Fig 4. Phylogenetic analyses of the β-strands 1 and 7 from bacterial KDPG and KDPGal aldolases. The phylogenetic
tree has been created using iTOL and shows the phylogenetic distribution KDPG/KDPGal-sequences used for identifying
the respective patterns (~6000 sequences) [42]. The sequence logos have been created using theWebLogo server [43, 44].
The overall height of the stack indicates the sequence conservation at that position, while the height of individual symbols
indicates the relative frequency of each amino acid at that position.
doi:10.1371/journal.pone.0156525.g004
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propanal (1) as electrophile (Fig 5). This approach has various advantages over measuring the
aldolases´ enzymatic activity using their natural substrates (2-keto-3-deoxy-gluconate/galacto-
nate-6-phosphate). First, conducting the assay in aldol direction yields an effective enantio-
meric excess (ee) under competitive conditions and not an apparent value from comparative
steady-state kinetics. Second, using the simplified substrate propanal leads to a simplified prod-
uct portfolio, whereas the natural electrophile glyceraldehyde-3-phosphate would yield mix-
tures of lactones, furanoses, and pyranoses including the respective diastereomers.
Either the mutation in the β7-sheet or the transferred strand β1 affected the stereoselectivity
(decrease of ee by up to -49%ee; Table 1). Combining both modifications strongly enhanced
the effect and resulted in a slightly reversed stereoselectivity of KDPG (ee = -5%) and KDPGal
(ee = 10%). Comparing these results with those fromWalters et al., the enantioselectivities [log
(E)] could be reproduced with the same tendency for the known mutants. However, for the
uncompetitive assay used by Walters et al. the selectivities were much more optimistic [45, 46].
Development of an Aldol-Screening for DERA
One challenge was to develop a comparable screening method for KDPG/KDPGal aldolases
and DERA. A screening in aldol direction should be applied to measure the ee of the newly
formed stereogenic center (in comparison to a retro-aldol based assay [47, 48]). In order to
design a comparable assay we used the same electrophile propanal (1) as above (Fig 5). The
choice of the nucleophile is restricted by the corresponding enzymes, pyruvate for KDPG/
KDPGal and acetaldehyde for DERA (Fig 6). The stereoselectivity of the respective DERA-cat-
alyzed aldol reaction was assessed in a model reaction by the generation of both enantiomers of
3-hydroxypentanal (6). For KDPG and KDPGal aldolase, the products 4 were analyzed by gas
chromatography using a chiral stationary phase. To be able to analyze the unstable aldol prod-
ucts 6 of DERA, they were derivatized. The formed hydrazones 7 [49–51] were extracted and
measured by HPLC. Because this procedure may cause lot-specific differences during
Fig 5. Model aldol reaction for testing the stereoselectivity of KDPG, KDPGal, and specific mutants.
The aldol reaction of propanal (1) and pyruvic acid (2) leads to the enantioselective generation of 3 and, by
acidic lactonization, to butyrolactone 4.
doi:10.1371/journal.pone.0156525.g005
Table 1. Results of the stereoselectivity assay with the variants of the pyruvate-dependent aldolases KDPG and KDPGal. Own experiments have
been carried out as triplicates from different enzyme-lots; standard-deviations are given for each ee. A negative control without enzyme did not show any
product formation. Complex mutations: chimβ1;KDPGal: V17L, V18I, P19A, V20I, I21L and chimβ1;KDPG: L9V, I10V, A11P, I12P, L13I.
KDPG %ee (4) log(E)* log(E)§ KDPGal %ee (4) log(E)* log(E)§
wt 91±2 1.33 4.6 wt -96±3 -1.69 -2.3
T161V 56±3 0.55 -0.15 V154T -79±4 -0.93 -0.85
chimβ1 79±1 0.93 - chimβ1 -49±3 -0.47 -
chimβ1 T161V -5±4 -0.04 - chimβ1 V154T 10±2 0.09 -
* Calculated from the enantiomeric excess (ee) value for the formation of compound 7 (Fig 5) using the equation log(E) = log[(-1-ee)/(ee-1)]
§ Values from Walters et al. [17], deduced from steady-state kinetics with natural substrates in retro-aldol direction.
doi:10.1371/journal.pone.0156525.t001
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derivatization and extraction, each series of measurements included a triplicate measurement
of DERA wt as a reference. The negative control without enzyme did not show any product
formation.
A fixed volume of cell free crude extract of each DERA variant was used for the screening
reactions whilst the expression level was controlled visually by means of SDS-PAGE (S3–S8
Figs). Only DERA variants T18D, T18C, and T18G had significantly lower expression levels
than DERA wt, and for the L20H mutant virtually no soluble protein was expressed (see S1 Fig
for details on the mutations).
Transfer of Key-Residues onto Homologous DERA
As both sites I12/V20 (β1-sheet) and V154/T161 (β7-sheet) were confirmed as important deter-
minants of KDPG stereoselectivity, we transferred them to corresponding sites in DERA.
These corresponding sites were identified, based on a structural alignment, as T18 and L20
(both β1-sheet) as well as A203 (β7-sheet), respectively (Fig 3A). For a first generation of DERA
variants, the respective sites were mutated using the degenerate codon NDT, that way includ-
ing twelve different amino acids, in order to exhaustively explore the effect of these positions
on stereoselectivity.
The results of the first generation of DERA variants show that T18 and L20 in the β1-sheet
have a strong influence on DERA stereoselectivity (Fig 7). Especially T18S (ee = 20%) and
T18R (ee = 23%) led to a decreased enantiomeric excess. These results support our hypothesis
that the homologous sites are transferable and indicate that T18 is more important for stereose-
lectivity than L20.
Of the variants of the A203 position in the β7-sheet, only A203S and A203G showed suffi-
cient activity to perform the aldol screening. The two variants contained amino acids of similar
or smaller size than the original alanine. A203G showed the largest effect on stereoselectivity
compared to DERA wt (ee = 88%); however, the overall effect is moderate compared to effects
due to variants of the T18 position.
Fig 6. Principle of KDPG, KDPGal, and DERA-catalyzed reactions for library screening (a) KDPG and KDPGal
aldolase, 275 mM propanal, 20 mM KPi, 1 M sodium pyruvate, pH 6.5, 30°C, 200 rpm, 18 h. (b) Acidified with sulfuric acid to
pH 1. (c) 0.1 mmol propanal, 1.3 eq. acetaldehyde, 20 μl DERA crude extract, 0.5 ml triethanol amine buffer (0.1 M, pH7),
5% (v/v) dimethyl sulfoxide, 25°C, 200 rpm, 18 h. (d) 0.5 ml dimethyl sulfoxide, 2 eq. 2,4-dinitrophenylhydrazine, 3 eq. conc.
HCl, 50°C, 2 h, 300 rpm.
doi:10.1371/journal.pone.0156525.g006
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With reference to these results, a second generation of DERA variants was constructed.
Double mutations of the positions T18 and A203 were created. As there is no smaller amino
acid than glycine, which resulted in the largest effect on stereoselectivity in A203G DERA, we
aimed at further expanding the binding pocket for the electrophile by deleting the amino acids
G204 and G205. Structural models generated from the DERA crystal structure by deleting
these residues, changing A203 to glycine, and minimization indicated that these deletions
(ΔG204, ΔG204 Δ205) should result in a retraction of the loop at the end of the β7-sheet (Fig
8). Furthermore, to study the effects of double mutations, combinations of the A203G and T18
variants were investigated.
The combination of A203G and T18S did not lead to a further decreased enantiomeric
excess (ee = 54%). The deletion of G204 and G205 in combination with A203G, respectively,
did not lead to a change in enantiomeric excess either. Finally, the combination of A203G, one
or two glycine deletions, and mutation in position T18 to serine decreased the enantioselectiv-
ity significantly (ee = 63-64%, Fig 9), although this value is higher than that obtained for the
A203G T18S variant above (ee = 54%).
Michaelis-Menten kinetics on the natural substrate of the DERA of the variant with the
highest change in enantioselectivity T18S as well as the wildtype enzyme were performed. The
results in Table 2 show an only ~3-fold decreased catalytic efficiency for T18S compared to the
wildtype, leading to a catalytic efficiency of ~36 s-1 mM-1.
Conclusions
Enzymes are attractive catalysts because of their strict stereoselectivity. In some cases natural
enantiocomplementary versions are available. Unfortunately, if an enantiocomplementary
enzyme is missing, synthetic applications are severely restricted. Although DERA is such an
example, this enzyme is still highly attractive for synthetic purposes [11, 53]. Various endeav-
ors, such as rational enzyme design and directed evolution approaches, were employed for dif-
ferent enzymes to invert their stereoselectivity [54–60]. For the pyruvate dependent aldolases
Fig 7. Enantiomeric excesses of the first generation variants of DERA at sites T18, L20, and A203, respectively. The eewas determined by the aldol
screening (Fig 6) using chiral HPLC. The error bars represent the standard deviation of triplet measurements. A negative control without enzyme did not
show any product formation. “*”: Results for variants with an activity lower than 2.0% of the DERA wt were omitted.
doi:10.1371/journal.pone.0156525.g007
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very convincing approaches for changing the stereoselectivity have been conducted [39, 40,
61]. However, to our knowledge, no alteration of the stereoselectivity of DERA has been
described so far.
Here, we present an approach that aims at transferring the stereoselectivity-determining
parts from homologous, pyruvate-dependent, and enantiocomplementary aldolases KDPG
and KDPGal onto DERA. In order to apply this promising strategy, the stereoselectivity-deter-
mining sites of KDPG and KDPGal were identified using MD simulations, geometric, and phy-
logenetic analyses. For the pyruvate-dependent aldolases, we demonstrated the importance of
I12/V20 (β1-sheet) and V154/T161 (β7-sheet) as stereoselectivity-determining sites, using a
novel assay working in aldol instead of retro-aldol direction of the catalyzed reaction to eluci-
date the stereochemistry of the respective products. The advantage of the novel assay is that it
is unbiased by non-competing effects contrary to previous assays exploiting the retro-aldol
reaction in separate reactions of the two enantiomers [17]; as a result, for mutation sites previ-
ously described, lower stereoselectivity inversions compared to previous work were observed
(Table 1). However, these obtained values reflect the synthetic capabilities more realistically.
Although it was not possible to completely invert the enantioselectivity of KDPG or KDPGal, it
was possible to pin-point I12/V20 (β1-sheet) and V154/T161 (β7-sheet) as essential residues
for stereoselectivity. Variants of these restricted sites allowed not only to reduce stereoselectiv-
ity but even inverted it compared to KDPG (ee = -5%) and KDPGal (ee = 10%). This demon-
strated that these sites are important for stereoselectivity.
We then transferred these sites onto DERA based on considerations derived from a struc-
tural superpositioning of the enzymes. The spatial positions of the stereoselectivity-determin-
ing sites should be the same because of their similar geometrical composition and their very
Fig 8. Comparison of DERAwt (blue) and the variant A203GΔG204 ΔG205 (grey). The sites G204 and G205
are highlighted in red in the wt structure. The models were generated based on PDB ID 1JCL [37] using USCF
Chimera [52].
doi:10.1371/journal.pone.0156525.g008
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same mode of action. Indeed, mutating the found sites caused a significant change in enantios-
electivity within the first series of mutations (best ee found for T18S: 20%). Combinations of
the identified stereoselectivity-determining sites did not further change the stereoselectivity.
DERA has a very different mechanism in realizing its stereoselectivity compared to the homol-
ogous pyruvate-dependent aldolase, thus, additional stereoselectivity-determining sites might
be involved as seen for the pyruvate-dependent aldolases. Hence, inversion of the stereoselec-
tivity of DERA is likely an especially challenging problem; obviously further stereo-determi-
nants of DERA must be characterized in future studies. However, the presented homologous
Fig 9. Enantiomeric excesses of the second generation of variants of DERA at sites T18 combined with A203G, A203GΔG204, and A203GΔG204
ΔG205, respectively. The eewas determined by the aldol screening (Fig 6) using chiral HPLC. The error bars represent the standard deviation of triple
measurements. A negative control without enzyme did not show any product formation. “*”: Results for variants with an activity lower than 2.0% of the DERA
wt were omitted.
doi:10.1371/journal.pone.0156525.g009
Table 2. Michaelis-Menten parameters from steady-state kinetics with 2-deoxy-d-ribose-5-phosphate (D5P) as substrate.
KM [mM] kcat [s
-1] kcat KM
-1[s-1 mM-1]
WT 0.29 ± 0.01 33.18 ± 0.66 114.72 ± 6.47
T18S 0.17 ± 0.01 6.05 ± 0.15 35.92 ± 2.59
doi:10.1371/journal.pone.0156525.t002
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grafting approach was shown to serve as a new entry point for difficult tasks for finding enan-
tiocomplementary enzymes.
Supporting Information
S1 Fig. Overview of deoCEC enzyme library construction. pET-21a(+)::deoCEC T18X: The
T18X variants were produced by RTH PCR using the deoCEC wt construct as DNA-template and
the different deoCEC_T18X_fwd oligonucleotides as forward primers and deoCEC_T18_rev as
reverse primer (S1 Table #17–26). The T18X (X: I,S,V) variants were produced by QuikChange
PCR using the deoCEC wt construct as DNA-template and deoCEC_T18I_fwd/deoCEC-T18S_fwd/
deoCEC-T18V_fwd as forward primers and deoCEC_T18I_rev/deoCEC-T18S_rev/deoCEC-
T18V_rev as reverse primers (S1 Table #27–32). pET-21a(+)::deoCEC L20X: The L20X variants
were produced by RTH PCR using the deoCEC wt construct as DNA-template and the different
deoCEC_L20X_fwd oligonucleotides as forward and deoCEC_L20_rev as reverse primer (S1 Table
#35–44). pET-21a(+)::deoCEC A203X: The A203X variants were produced by RTH PCR using the
deoCEC wt construct as DNA-template and the deoCEC_A203_fwd as forward and the degenerated
oligonucleotide deoCEC_L20NDT_rev as reverse primer (S1 Table #45 and #46). The A203X (X: R,
D,C,S) variants were produced by RTH PCR using the deoCEC wt construct as DNA-template and
the deoCEC_A203_fwd as forward and the different deoCEC_A203X_rev oligonucleotides as reverse
primer (S1 Table #45 and #47–50). pET-21a(+)::deoCEC T18X,A203G: The variants with changes
of amino acid position T18 and A203 were produced by QuikChange PCR using the pET-21a(+)::
deoCEC A203G plasmid as DNA-template and the different deoCEC_T18X_fwd oligonucleotides as
forward and the different deoCEC-T18X_rev oligonucleotides as reverse primers (S1 Table #27–34).
The enzyme variants with either one or two glycine deletions were produced by RTH PCR using
the deoCEC wt construct as DNA-template and the oligonucleotides deoCEC_ΔG204_fwd or deo-
CEC_ΔG204,ΔG205_fwd as forward and the oligonucleotide deoCEC_A203_rev as reverse primer
(S1 Table #51–53). The variants with the A203Gmutations and either one or two glycine deletions
were produced by RTH PCR using the deoCEC wt construct as DNA-template and the oligonucleo-
tides deoCEC_ΔG204_fwd or deoCEC_ΔG204,ΔG205_fwd as forward and the oligonucleotide deo-
CEC_A203G_rev as reverse primer (S1 Table #51–52 and #54). The enzyme variants with A203G,
either one or two glycin deletions, and T18X (X: S,A,I,V) were produced by QuikChange PCR
using the pET-21a(+)::deoCEC A203G,ΔG204 or pET-21a(+)::deoCEC A203G,ΔG204,ΔG205 plas-
mid as DNA-template and the different deoCEC_T18X_fwd oligonucleotides as forward and the
different deoCEC-T18X_rev oligonucleotides as reverse primers (S1 Table #27–34).
(TIF)
S2 Fig. SDS-PAGE of purification samples of KDPG and KDPGal aldolase. Gel (NuPAGE
4–12% Bis-TRIS Gel, Invitrogen) with colloidal Coomassie stain. M – marker; CE – crude
extract; CFCE – cell free crude extract; FT – chromatographic flow through; W30 – washing
with 30 mM imidazole; E250 – elution with 250 mM imidazole. Equal amounts of protein
(determined by Bradford assay) were subjected to the SDS-PAGE.
(TIF)
S3 Fig. SDS-PAGE of DERA T18NDT variants. 4–12% Bis-TRIS Gel with colloidal Coomas-
sie stain. 10 μL of a 1:100 dilution of cell-free crude extracts were used, the standard was
Roti1-Mark 10–150. WT: DERA wildtype, the mutation is represented in the single-letter
code.
(TIF)
S4 Fig. SDS-PAGE of DERA L20NDT variants. 4–12% Bis-TRIS Gel with colloidal Coomas-
sie stain. 10 μL of a 1:100 dilution of cell-free crude extracts were used, the standard was
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Roti1-Mark 10–150. WT: DERA wildtype, the mutation is represented in the single-letter
code.
(TIF)
S5 Fig. SDS-PAGE of DERA A203NDT variants. 4–12% Bis-TRIS Gel with colloidal Coo-
massie stain. 10 μL of a 1:100 dilution of cell-free crude extracts were used, the standard was
Roti1-Mark 10–150. WT: DERA wildtype, the mutation is represented in the single-letter
code.
(TIF)
S6 Fig. SDS-PAGE of DERA A203G/T18X variants. 4–12% Bis-TRIS Gel with colloidal Coo-
massie stain. 10 μL of a 1:100 dilution of cell-free crude extracts were used, the standard was
Roti1-Mark 10–150. WT: DERA wildtype, 29: DERA A203G/T18S, 30: DERA A203G/T18A,
31: DERA A203G/T18I, 32: DERA A203G/T18V.
(TIF)
S7 Fig. SDS-PAGE of DERA variants with glycine deletions. 4–12% Bis-TRIS Gel with col-
loidal Coomassie stain. 10 μL of a 1:100 dilution of cell-free crude extracts were used, the stan-
dard was Roti1-Mark 10–150. WT: DERA wildtype, 1: DERA ΔG204, 2: ΔG204/ΔG205, 3:
A203G/ΔG204, 4: A203G/ΔG204/ΔG205.
(TIF)
S8 Fig. SDS-PAGE of DERA triple and quadruples variants. 4–12% Bis-TRIS Gel with colloi-
dal Coomassie stain. 10 μL of a 1:100 dilution of cell-free crude extracts were used, the standard
was Roti1-Mark 10–150. 1: DERA wildtype, 2: A203G/ΔG204/T18I, 3: A203G/ΔG204/T18V,
4: A203G/ΔG204/T18A, 5: A203G/ΔG204/T18S, 6: A203G/ΔG204/ΔG205/T18I, 7: A203G/
ΔG204/ΔG205/T18V, 8: A203G/ΔG204/ΔG205/T18A, 9: A203G/ΔG204/ΔG205/T18S.
(TIF)
S1 Table. Primers used for creation of KDPG, KDPGal, and DERA enzyme variants. [Phos]
indicates a phosphorylation at the 5’ position.
(PDF)
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